Biden says he and Jill WILL receive COVID-19 vaccine booster shot when it becomes available in September as officials prepare to roll out the third jab
- President Joe Biden says he and First Lady Jill Biden plan to get the COVID-19 vaccine booster shot when they becomes available
- Because of his age, the President was among the first people to be eligible for the vaccine in December 2020
- Health officials announced on Wednesday that booster shots for the Pfizer and Moderna vaccines will roll out on September 20
- Studies suggest COVID-19 vaccines’ effectiveness wanes over time and the Indian ‘Delta’ variant has the ability to cause breakthrough cases at a higher rate
President Joe Biden said on Thursday that he and First Lady Jill Biden plan on receiving COVID-19 vaccine booster shots when available in September.
At 78 years old, Biden was eligible for the vaccine as early as December 2020, and received his first shot on December 21, he told Good Morning America’s George Stephanopoulos.
The third doses will be rolled out starting September 20, and any American who received either the Pfizer-BioNTech or Moderna vaccine is eligible for the third shot eight months after receiving the second.
Because Biden received his final dose on on January 11, he will be eligible for a booster when they become available.
Health experts believe booster shots are necessary due to the waning immunity of the vaccines and the ability for the Indian ‘Delta’ variant to cause breakthrough cases.
President Joe Biden (pictured) said during an interview with Good Morning America on Thursday that he and his wife, Jill, plan to receive vaccine boosters when they become available
Both the President and the first lady will be eligible to received third doses when they roll out on September 20. Pictured: Joe Biden and Jill Biden walk from Marine One as they return from Camp David, July 2021
‘We’re gonna get the booster shots. And it’s something that I think – you know, because we got our shots all the way back in I think December,’ Biden told Good Morning America.
‘So it’s past time…Yes, we will get the booster shots.’
The White House announced that booster shots will soon roll out across the United States on Wednesday after studies showed that protection against mild and moderate disease decreased over time.
One study found that vaccines’ effectiveness against COVID-19 diagnoses dropped from 96 percent to 80 percent in New York state between May 2021 and July 2021.
Another study found the effectiveness of the shots against infections in nursing home residents was 75 percent. Post-Delta, this had fallen to 53 percent.
‘The Delta variant is twice as transmissible as the Alpha variant, it’s dangerous, and it continues to spread’ Biden said during a news conference on Wednesday,
‘Vaccines are the key to stopping it from making progress.’
While the shot’s ability to defend a person from contracting the virus decreases over time, fully vaccinated people are still very unlikely to suffer hospitalization or death from COVID-19.
However, White House officials said at the press conference that they have concerns the decline of the vaccines’ effectiveness will continue.
Declining efficacy is common among vaccines.
The flu shot is required every year due to how quickly the efficacy declines, and even some longer term vaccines like the tetanus shots require boosters every year.
The new booster shot directives will effect over 150 million Americans who are fully vaccinated with either the Moderna or Pfizer vaccine.
Almost 14 million Americans have received the Johnson & Johnson vaccine, and they remain in limbo, with no plan for boosters for them in place yet.
While there are no plans yet laid out, the U.S. Food and Drug Administration says they plan to eventually approve booster shots for J&J recipients, but cannot yet do so due to a lack of data.
‘We…anticipate booster shots will likely be needed for people who received the J&J vaccine,’ a joint statement from the U.S. Department of Health and Human Services and public health experts said on Wednesday.
‘Administration of the J&J vaccine did not begin in the U.S. until March 2021, and we expect more data on J&J in the next few weeks. With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well.’
Nearly 200 million Americans – 60 percent of the population, have received at least one dose of a COVID-19 vaccine.
Just over 50 percent of Americans are fully vaccinated.